SATANG ANN: Open Payments
NPI 1487380929 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $145 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $228 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| Supernus Pharmaceuticals, Inc. | 1 | $87 |
Products named: Auvelity, COBENFY, REXULTI, Qelbree.
Industry payments across TX — which companies pay providers there.
